Ad
related to: how to protect against shedding of virus vaccine- Ask Your Doctor
Learn how to help prevent
COVID-19
- Multilayered Prevention
Explore a multilayered
approach to COVID‑19 prevention
- COVID-19 Resources
Access COVID-19 resources
for immunocompromised people
- Stay Updated
Get updates about COVID-19
programs, products, and services.
- Ask Your Doctor
Search results
Results from the WOW.Com Content Network
Vaccine shedding is a form of viral shedding [1] [2] which can occasionally occur following a viral infection caused by an attenuated (or "live virus") vaccine. Illness in others resulting from transmission through this type of viral shedding is rare.
The term is variously used to refer to viral particles shedding from a single cell, from one part of the body into another, [2] and from a body into the environment, where the virus may infect another. [3] Vaccine shedding is a form of viral shedding which can occur in instances of infection caused by some attenuated (or "live virus") vaccines.
Vaccination with a live, but attenuated, virus can produce immunity to more dangerous forms of the virus. These attenuated viruses produce little or no illness in most people. However, the live virus multiplies briefly, may be shed in body fluids or excrement, and can be contracted by another person. If this contact produces immunity and ...
Additionally, scientists are developing new mRNA vaccines against H5N1. This type of vaccine, which was first used against Covid-19, can be more quickly tailored to particular viral strains and ...
An attenuated vaccine (or a live attenuated vaccine, LAV) is a vaccine created by reducing the virulence of a pathogen, but still keeping it viable (or "live"). [1] Attenuation takes an infectious agent and alters it so that it becomes harmless or less virulent. [2] These vaccines contrast to those produced by "killing" the pathogen ...
Those to whom the weakened virus might pose a heightened risk were recommended to wait for the release of killed-virus vaccines, which followed weeks to months later. [citation needed] Vaccine uptake by the public was very low in the UK, but predicted by greater belief in the vaccine's efficacy and safety and a greater perceived risk of the ...
The Food and Drug Administration on Monday approved a vaccine that is administered to pregnant people to protect their babies from RSV, or respiratory syncytial virus, through their first six months.
According to the U.S. Department of Health and Human Services, the CDC began allowing the ACAM2000 smallpox vaccine to be used as a vaccine against monkeypox last month.
Ad
related to: how to protect against shedding of virus vaccine